← All trials
NCT05830539
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2022
- Primary completion
- Mar 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Apr 26, 2023
- Last posted
- May 17, 2023
- Enrollment
- 240
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- InxMed (Shanghai) Co., Ltd.Lead sponsor
- Fudan UniversityOverall official - principal investigator
- Chinese Academy of Medical SciencesOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.